Medtech

BrainQ’s investigational cloud-based technology aims to reduce disability and promote neuro recovery for stroke victims.

The company’s devices extend life expectancy for patients with late-stage heart disease while also improving their quality of life.

The company provides its AI technology to pharmaceutical companies to enhance R&D for new drugs.

AI solutions in healthcare are becoming increasingly commercialized as the sector matures.

As the nature of healthcare changes, several companies rooted in Singapore are developing new products and services that will reshape patient care.

Last month, Alpha Tau was granted Breakthrough Device Designation by the FDA for its Alpha DaRT technology.

The company’s healthcare AI platform is currently used by radiologists in health networks, hospitals, and radiology groups globally and has analyzed over 8 million cases to date.

These Southeast Asian startups that KrASIA highlighted in the first half of 2021 have one thing in common: they each identified a relatively unexplored area and built their business around it.